Biomerica, Inc. (BMRA) - יחס מהיר

Biomerica, Inc. (BMRA) is protected by EZ Smart patents and strict FDA oversight, which hinders competitor expansion. Business development relies on expanding the pharmacy network and gaining recognition of its methodologies by insurance companies. The price history on the GURU.Markets chart demonstrates the asset's dynamics, where the current figure is 1.28. High confidence among medical centers in product quality confirms the brand's conservative and reliable status in the market.

Investors assess business resilience through the ability to instantaneously settle short-term liabilities without liquidating inventory. This metric aggregates cash and accounts receivable, excluding illiquid goods from the calculation. For Biomerica, Inc. (BMRA), this is critical when financing the environmental modernization of laboratories and implementing recyclable packaging. By analyzing the current acid-test ratio, one can determine whether there is sufficient liquidity to develop ESG standards in an environment of expensive loans.